Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 51146
Gene Symbol: A4GNT
A4GNT
0.010 AlteredExpression disease LHGDN Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer. 16441422 2006
Entrez Id: 79719
Gene Symbol: AAGAB
AAGAB
0.100 Biomarker disease HPO
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.020 AlteredExpression disease BEFREE Expression of the MDR1 gene was detected in all the pancreatic tumors examined and was significantly higher than that in normal pancreas (P < 0.05). 8766529 1996
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.020 AlteredExpression disease BEFREE Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ<sub>2</sub>) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors. 29287249 2018
Entrez Id: 1244
Gene Symbol: ABCC2
ABCC2
0.010 AlteredExpression disease LHGDN Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer. 19020751 2008
Entrez Id: 8714
Gene Symbol: ABCC3
ABCC3
0.010 Biomarker disease BEFREE These data suggest that MRP3 and MRP5 are involved in drug resistance of pancreatic tumors and that quantitative analysis of their expression may contribute to predict the benefit of chemotherapy in patients with pancreatic cancer. 15688370 2005
Entrez Id: 10057
Gene Symbol: ABCC5
ABCC5
0.010 Biomarker disease BEFREE These data suggest that MRP3 and MRP5 are involved in drug resistance of pancreatic tumors and that quantitative analysis of their expression may contribute to predict the benefit of chemotherapy in patients with pancreatic cancer. 15688370 2005
Entrez Id: 28
Gene Symbol: ABO
ABO
0.300 Biomarker disease CTD_human Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. 19648918 2009
Entrez Id: 28
Gene Symbol: ABO
ABO
0.300 Biomarker disease CTD_human Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 26098869 2015
Entrez Id: 84680
Gene Symbol: ACCS
ACCS
0.010 Biomarker disease BEFREE Does surgical approach affect outcomes of enucleation for benign and low-grade pancreatic tumors? An ACS-NSQIP evaluation. 31076257 2019
Entrez Id: 65057
Gene Symbol: ACD
ACD
0.100 Biomarker disease HPO
Entrez Id: 55902
Gene Symbol: ACSS2
ACSS2
0.010 Biomarker disease BEFREE Does surgical approach affect outcomes of enucleation for benign and low-grade pancreatic tumors? An ACS-NSQIP evaluation. 31076257 2019
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.010 Biomarker disease BEFREE When CAG-CAT-MitoTimer mice were crossbred with various tissue-specific (muscle, adipose tissue, kidney, and pancreatic tumor) or global Cre transgenic mice, the double transgenic offspring showed MitoTimer expression in tissue-specific or global manner. 29274400 2019
Entrez Id: 90
Gene Symbol: ACVR1
ACVR1
0.010 AlteredExpression disease BEFREE ALK5 and SKR1 mRNA levels were 6.8- and 9-fold greater in the pancreatic tumors in comparison with the corresponding levels in the normal pancreas. 8760600 1996
Entrez Id: 91
Gene Symbol: ACVR1B
ACVR1B
0.010 GeneticVariation disease BEFREE We disrupted Acvr1b specifically in pancreata of mice (Acvr1b(flox/flox);Pdx1-Cre mice) and crossed them with LSL-KRAS(G12D) mice, which express an activated form of KRAS and develop spontaneous pancreatic tumors. 26408346 2016
Entrez Id: 94
Gene Symbol: ACVRL1
ACVRL1
0.020 Biomarker disease BEFREE These results show that ALK1 activation in pancreatic tumor cells is antioncogenic by inducing ALK5-independent growth inhibition and by blocking TGF-beta/ALK5-mediated epithelial-to-mesenchymal transdifferentiation and, possibly, invasion and metastatic progression. 17230504 2007
Entrez Id: 94
Gene Symbol: ACVRL1
ACVRL1
0.020 AlteredExpression disease BEFREE Rare ALK1 expression is not induced by ALK translocation, and ALK is unlikely to be a therapeutic target in pancreatic tumors. 23851431 2013
Entrez Id: 101
Gene Symbol: ADAM8
ADAM8
0.010 Biomarker disease LHGDN Hypoxia-dependent expression of ADAM8 in human pancreatic cancer cell lines. 18566576 2008
Entrez Id: 9289
Gene Symbol: ADGRG1
ADGRG1
0.010 AlteredExpression disease LHGDN Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells. 17932623 2008
Entrez Id: 128
Gene Symbol: ADH5
ADH5
0.010 Biomarker disease LHGDN Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with pancreatic cancer. 18095160 2008
Entrez Id: 55256
Gene Symbol: ADI1
ADI1
0.010 AlteredExpression disease BEFREE Further, we observe an inverse correlation between MTCBP-1 and MT1-MMP expression both in cultured cell lines and human pancreatic tumors. 30487181 2019
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.010 AlteredExpression disease BEFREE We show that the level and expression of both adiponectin receptors are decreased in pancreatic tumors relative to normal pancreatic tissue. 29156726 2017
Entrez Id: 133
Gene Symbol: ADM
ADM
0.010 Biomarker disease LHGDN Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. 17290391 2007
Entrez Id: 177
Gene Symbol: AGER
AGER
0.050 AlteredExpression disease BEFREE Inhibition of autophagy with chloroquine or genetic ablation of receptor for advanced glycation end products (RAGE) resulted in decreased propensity for NET formation, decreased serum DNA and decreased citrullinated histone H3 expression in the pancreatic tumor microenvironment. 25908451 2015
Entrez Id: 177
Gene Symbol: AGER
AGER
0.050 AlteredExpression disease BEFREE Further, suppression of RAGE expression by RNA interference increased the sensitivity of pancreatic tumor cells to oxidative injury. 21126167 2011